Features of immune response against influenza infection in animals vaccinated with recombinant cross-protective vaccine
Generating cross-reactive vaccines aimed at targeting all human influenza A virus subtypes is among high priority tasks in contemporary vaccinology. Such vaccines will be primarily demanded during pre-pandemic period as well as used to prime some population cohorts prior to vaccination with standard...
Guardado en:
Autores principales: | L. M. Tsybalova, L. A. Stepanova, A. V. Korotkov, M. A. Shuklina, M. V. Zaitseva, V. I. Grishchenko, R. Yu. Kotlyarov |
---|---|
Formato: | article |
Lenguaje: | RU |
Publicado: |
Sankt-Peterburg : NIIÈM imeni Pastera
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/772c70c0aa8746b58a1050dd91f199af |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Intranasal immunization with a recombinant protein based on the M2e peptide and second subunit of influenza A viral hemagglutinin fragment induces a cross-protective humoral and Tcell response in mice
por: M. A Shuklina, et al.
Publicado: (2020) -
Immunogenicity and protective efficacy of prime-boost immunization in mice vaccinated with live and inactivated influenza A (H5N1) vaccines
por: I. Losev, et al.
Publicado: (2019) -
Influenza Vaccination Programs for Healthcare Personnel: Organizational Issues and Beyond
por: Helena C. Maltezou, et al.
Publicado: (2021) -
IMMUNOGENICITY OF ADJUVANT INFLUENZA VACCINE FOR PREGNANT WOMEN
por: M. P. Kostinov, et al.
Publicado: (2017) -
STUDIES ON PROTECTIVE EFFECTS OF A VACCINE, BASED ON RECOMBINANT Ag85, TB10 AND FliC PROTEINS
por: V. V. Yeremeev, et al.
Publicado: (2017)